Publikationen in Zusammenarbeit mit Forschern von Hospital de Cruces (29)

2023

  1. Multilocus Genetic Profile Reflecting Low Dopaminergic Signaling Is Directly Associated with Obesity and Cardiometabolic Disorders Due to Antipsychotic Treatment

    Pharmaceutics, Vol. 15, Núm. 8

  2. Psychosis and substance abuse increase the COVID-19 mortality risk

    Psychological Medicine, Vol. 53, Núm. 9, pp. 4236-4244

2022

  1. In Vitro Antifungal Activity of Ibrexafungerp (SCY-078) Against Contemporary Blood Isolates From Medically Relevant Species of Candida: A European Study

    Frontiers in Cellular and Infection Microbiology, Vol. 12

2021

  1. Cognitive Enhancers in Schizophrenia: A Systematic Review and Meta-Analysis of Alpha-7 Nicotinic Acetylcholine Receptor Agonists for Cognitive Deficits and Negative Symptoms

    Frontiers in Psychiatry, Vol. 12

  2. Quantifying the patient's perspective in neuromyelitis optica spectrum disorder: Psychometric properties of the SymptoMScreen questionnaire

    PLoS ONE, Vol. 16, Núm. 7 July

  3. Regret and Therapeutic Decisions in Multiple Sclerosis Care: Literature Review and Research Protocol

    Frontiers in Neurology, Vol. 12

2014

  1. Effectiveness of teleassistance at improving quality of life in people with neuromuscular diseases

    The Spanish Journal of Psychology, Vol. 17, pp. 1-9

  2. Pharmacogenetics of MicroRNAs and MicroRNAs biogenesis machinery in pediatric acute lymphoblastic leukemia

    PLoS ONE, Vol. 9, Núm. 3

2013

  1. Polymorphisms in the methotrexate transport pathway: A new tool for MTX plasma level prediction in pediatric acute lymphoblastic leukemia

    Pharmacogenetics and Genomics, Vol. 23, Núm. 2, pp. 53-61

2012

  1. Do the same factors predict outcome in schizophrenia and non-schizophrenia syndromes after first-episode psychosis? A two-year follow-up study

    Journal of Psychiatric Research, Vol. 46, Núm. 6, pp. 774-781

  2. Las representaciones de apego y el estrés en las madres de niños nacidos pretérmino de muy bajo peso a los 2 años

    Anales de Pediatria, Vol. 76, Núm. 6, pp. 329-335

  3. Longitudinal changes of insight in first episode psychosis and its relation to clinical symptoms, treatment adherence and global functioning: One-year follow-up from the Eiffel study

    European Psychiatry, Vol. 27, Núm. 1, pp. 43-49

  4. Maternal attachment representations and the development of very low birth weight premature infants at two years of age

    Infant Mental Health Journal, Vol. 33, Núm. 5, pp. 477-488

  5. Similarities in early course among men and women with a first episode of schizophrenia and schizophreniform disorder

    European Archives of Psychiatry and Clinical Neuroscience, Vol. 262, Núm. 2, pp. 95-105

2011

  1. Cognitive performance and smoking in first-episode psychosis: The self-medication hypothesis

    European Archives of Psychiatry and Clinical Neuroscience, Vol. 261, Núm. 4, pp. 241-250

  2. Executive functioning correctly classified diagnoses in patients with first-episode psychosis: Evidence from a 2-year longitudinal study

    Schizophrenia Research, Vol. 126, Núm. 1-3, pp. 77-80

  3. Polymorphisms of the SLCO1B1 gene predict methotrexate-related toxicity in childhood acute lymphoblastic leukemia

    Pediatric Blood and Cancer, Vol. 57, Núm. 4, pp. 612-619

2009

  1. Chromosome instability in lymphocytes of children with coeliac disease

    Journal of Pediatric Gastroenterology and Nutrition, Vol. 49, Núm. 1, pp. 143-146

  2. Systematic review of pharmacological treatments in fragile X syndrome

    BMC Neurology, Vol. 9, pp. 53

2008

  1. Specific binding of [3H]Ro 19-6327 (lazabemide) to monoamine oxidase B is increased in frontal cortex of suicide victims after controlling for age at death

    European Neuropsychopharmacology, Vol. 18, Núm. 1, pp. 55-61